Of 10 studies reported in a recent review that examined BBB integrity in AD compared to controls using the “CSF/serum albumin index,” six found evidence of BBB disruption, and four did not (Bowman and Quinn, 2008). This evidence concerns the gene ALB and Alzheimer disease.